Bellevue Asset Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-29
| Closed | -$3K | – | 600 |
|
|
2021
Q3 | $3K | Buy |
29
+10
| +53% | +$1.03K | ﹤0.01% | 489 |
|
|
2021
Q2 | $3K | Sell |
19
-2
| -10% | -$316 | ﹤0.01% | 488 |
|
|
2021
Q1 | $2K | Sell |
21
-3
| -13% | -$286 | ﹤0.01% | 612 |
|
|
2020
Q4 | $3K | Buy |
24
+1
| +4% | +$125 | ﹤0.01% | 563 |
|
|
2020
Q3 | $2K | Hold |
23
| – | – | ﹤0.01% | 583 |
|
|
2020
Q2 | $4K | Hold |
23
| – | – | ﹤0.01% | 453 |
|
|
2020
Q1 | $4K | Buy |
23
+13
| +130% | +$2.26K | ﹤0.01% | 432 |
|
|
2019
Q4 | $2K | Buy |
+10
| New | +$2K | ﹤0.01% | 469 |
|